BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10410437)

  • 1. Transplantation without immunosuppression: what the future may hold.
    Orosz CG
    Cleve Clin J Med; 1999; 66(7):395-6. PubMed ID: 10410437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reviewing the mechanism of peripheral tolerance in clinical transplantation.
    Suciu-Foca N; Cortesini R
    Contrib Nephrol; 2005; 146():132-142. PubMed ID: 15567927
    [No Abstract]   [Full Text] [Related]  

  • 3. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
    Svobodova E; Gazdic T; Kubanek M; Vymetalova J; Voska L; Kment M; Lanska V; Kolesar L; Urban M; Netuka I; Pirk J; Melenovsky V; Kautzner J; Slavcev A; Malek I
    Transpl Int; 2016 Jan; 29(1):63-72. PubMed ID: 26340387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.
    Kozlowski T; Shimizu A; Lambrigts D; Yamada K; Fuchimoto Y; Glaser R; Monroy R; Xu Y; Awwad M; Colvin RB; Cosimi AB; Robson SC; Fishman J; Spitzer TR; Cooper DK; Sachs DH
    Transplantation; 1999 Jan; 67(1):18-30. PubMed ID: 9921791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marking a path to transplant tolerance.
    Seyfert-Margolis V; Turka LA
    J Clin Invest; 2008 Aug; 118(8):2684-6. PubMed ID: 18654643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
    Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
    J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and transplantation: a clinical perspective.
    Gaston RS
    Transplant Sci; 1994 Dec; 4 Suppl 1():S9-19. PubMed ID: 7627452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tolerance in clinical organ transplantation.
    Fändrich F
    Nephrol Dial Transplant; 2006 May; 21(5):1170-3. PubMed ID: 16504976
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of immune tolerance in liver transplantation].
    Pons JA; Revilla-Nuin B; Ramírez P; Baroja-Mazo A; Parrilla P
    Gastroenterol Hepatol; 2011 Mar; 34(3):155-69. PubMed ID: 21376423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytokines in transplantation tolerance: lessons learned from gene-knockout mice.
    Lakkis FG
    J Am Soc Nephrol; 1998 Dec; 9(12):2361-7. PubMed ID: 9848793
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance assays: measuring the unknown.
    Newell KA; Larsen CP
    Transplantation; 2006 Jun; 81(11):1503-9. PubMed ID: 16770237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation immunology: what the clinician needs to know for immunotherapy.
    Rosen HR
    Gastroenterology; 2008 May; 134(6):1789-801. PubMed ID: 18471555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart transplantation--from immunological point of view].
    Nomoto K
    Jpn Circ J; 1993; 57 Suppl 4():1261-4. PubMed ID: 7966960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.